Biogen, Inc. (BIIB)
218.11
+1.33
(+0.61%)
USD |
NASDAQ |
Aug 24, 16:00
218.11
0.00 (0.00%)
After-Hours: 20:00
Biogen Net Income (Quarterly) : 97.50M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 97.50M |
| March 31, 2026 | 319.50M |
| December 31, 2025 | -48.90M |
| September 30, 2025 | 466.50M |
| June 30, 2025 | 634.80M |
| March 31, 2025 | 240.50M |
| December 31, 2024 | 266.80M |
| September 30, 2024 | 388.50M |
| June 30, 2024 | 583.60M |
| March 31, 2024 | 393.40M |
| December 31, 2023 | 248.90M |
| September 30, 2023 | -68.30M |
| June 30, 2023 | 593.30M |
| March 31, 2023 | 387.60M |
| December 31, 2022 | 549.50M |
| September 30, 2022 | 1.135B |
| June 30, 2022 | 1.059B |
| March 31, 2022 | 218.50M |
| December 31, 2021 | -20.50M |
| September 30, 2021 | 318.10M |
| June 30, 2021 | 1.026B |
| March 31, 2021 | 404.60M |
| December 31, 2020 | 357.60M |
| September 30, 2020 | 703.90M |
| June 30, 2020 | 1.606B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.393B |
| December 31, 2019 | 1.440B |
| September 30, 2019 | 1.546B |
| June 30, 2019 | 1.494B |
| March 31, 2019 | 1.409B |
| December 31, 2018 | 944.90M |
| September 30, 2018 | 1.443B |
| June 30, 2018 | 915.00M |
| March 31, 2018 | 1.171B |
| December 31, 2017 | -166.30M |
| September 30, 2017 | 1.226B |
| June 30, 2017 | 862.80M |
| March 31, 2017 | 747.50M |
| December 31, 2016 | 647.90M |
| September 30, 2016 | 1.030B |
| June 30, 2016 | 1.048B |
| March 31, 2016 | 969.20M |
| December 31, 2015 | 828.70M |
| September 30, 2015 | 1.019B |
| June 30, 2015 | 924.82M |
| March 31, 2015 | 820.17M |
| December 31, 2014 | 882.58M |
| September 30, 2014 | 856.12M |
| June 30, 2014 | 723.13M |
| March 31, 2014 | 479.73M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | -114.65M |
| AbbVie, Inc. | 3.604B |
| Gilead Sciences, Inc. | -10.50B |
| Vertex Pharmaceuticals, Inc. | 1.100B |
| Amgen, Inc. | 2.375B |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 2.622B |
| Total Expenses (Quarterly) | 2.525B |
| EPS Diluted (Quarterly) | 0.6557 |
| Enterprise Value | 39.09B |
| Gross Profit Margin (Quarterly) | 61.37% |
| Profit Margin (Quarterly) | 3.72% |
| Earnings Yield | 2.59% |
| Operating Earnings Yield | 5.85% |
| Normalized Earnings Yield | 4.189 |